|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61K 47/64 | (2017.01) | ||
| A61K 47/60 | (2017.01) | ||
| A61K 47/59 | (2017.01) | ||
| A61K 38/22 | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Patento numeris | 3384925 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18169490.2 |
| Europos patento paraiškos padavimo data | 2013-07-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 20120081475 | 2012-07-25 | KR |
| (72) |
Jung, Sung Youb, KR
Kim, Jin-Sun, KR
Jang, Myung Hyun, KR
Lee, Sang Hyun, KR
Choi, In Young, KR
Kwon, Se Chang, KR
|
| (73) |
Hanmi Pharm. Co., Ltd.,
214 Muha-ro Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-958,
KR
|
| (54) | COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE |
| COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE |